![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Once-Daily Sofosbuvir With GS-5816 for
8 Weeks With or Without Ribavirin in Patients
With HCV Genotype 3 Without Cirrhosis
Result in High Rates of SVR12:
The ELECTRON-2 Study
|
|
|
Reported by Jules Levin
AASLD 2014 Boston Nov 8-11
Edward J. Gane1, Robert H. Hyland2, Di An2, Evguenia Svarovskaia2,
John McNally2, Diana M. Brainard2, William T. Symonds2,
John G. McHutchison2, Catherine A. Stedman3
1Auckland Clinical Studies, Auckland, New Zealand; 2Gilead Sciences, Inc.,
Foster City, CA; 3Christchurch Clinical Studies Trust, Christchurch, New Zealand
![AASLD1.gif](../images/111014/111014-13/AASLD1.gif)
![AASLD2.gif](../images/111014/111014-13/AASLD2.gif)
![AASLD3.gif](../images/111014/111014-13/AASLD3.gif)
![AASLD4.gif](../images/111014/111014-13/AASLD4.gif)
![AASLD5.gif](../images/111014/111014-13/AASLD5.gif)
![AASLD6.gif](../images/111014/111014-13/AASLD6.gif)
![AASLD7.gif](../images/111014/111014-13/AASLD7.gif)
![AASLD8.gif](../images/111014/111014-13/AASLD8.gif)
![AASLD9.gif](../images/111014/111014-13/AASLD9.gif)
![AASLD10.gif](../images/111014/111014-13/AASLD10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|